Navigating Clinical Trials in Japan: From Regulatory Strategy to Operational Success

In today's dynamic global pharmaceutical landscape, understanding Japan's regulatory environment is crucial. This virtual session explores strategies for drug development in Japan, including its role in global Phase III studies and PMDA interactions. We examine unique aspects of Japanese clinical trials, addressing challenges and solutions. Through case studies participants will learn to navigate Japan's regulatory landscape and optimize clinical development in this key market.
This webinar covers:

  • Navigating Japan's Regulatory Landscape
  • Achieving Operational Excellence in Japanese Clinical Trials
  • Featured Case Studies
     

Watch now

Return to Insights Center

Related Insights

Blog

RNA-based therapies: Aligning CMC strategies with “borrowed” FDA regulatory guidance

Jun 30, 2025

Whitepaper

Optimizing the Route to Regulatory Approval for a Novel Vaccine

Aug 18, 2023

Video

How to transition existing trials under EU-CTR

Feb 1, 2023

Webinar

How to navigate China’s regulatory environment

Feb 15, 2023

Whitepaper

The Chinese Pharmaceutical Market: Size, R&D, Regulations, Market Access and Innovations

Mar 9, 2023

Playbook

Mitigating risk, protecting potential: Practical strategies that position cell and gene therapy development for success

Mar 28, 2023

Report

New Medicines, Novel Insights: Advancing rare disease drug development

May 22, 2023

Report

New Medicines, Novel Insights: Accelerating development of cell and gene therapies

May 22, 2023

Webinar

Assessing appropriate use of ECAs in clinical trials

May 28, 2023

Blog

Celebrating 40 Years of Rare Disease Progress: WODC Highlights

Jun 6, 2023

Blog

Population variability: important considerations in vaccine development

Jun 14, 2023

Whitepaper

How to prepare for Policy 0070: Challenges and opportunities for clinical data publication in the EU

Jun 28, 2023

Related Insights

Blog

RNA-based therapies: Aligning CMC strategies with “borrowed” FDA regulatory guidance

Jun 30, 2025

Whitepaper

Optimizing the Route to Regulatory Approval for a Novel Vaccine

Aug 18, 2023

Video

How to transition existing trials under EU-CTR

Feb 1, 2023

Webinar

How to navigate China’s regulatory environment

Feb 15, 2023

Whitepaper

The Chinese Pharmaceutical Market: Size, R&D, Regulations, Market Access and Innovations

Mar 9, 2023

Playbook

Mitigating risk, protecting potential: Practical strategies that position cell and gene therapy development for success

Mar 28, 2023

Show more